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Regulation of Oxygen Distribution in Tissues by Endothelial
Nitric Oxide
Victor M. Victor, Cristina Nun˜ez, Pilar D’Oco´n, Cormac T. Taylor,
Juan V. Esplugues,* Salvador Moncada*
Abstract—Nitric oxide (NO) decreases cellular oxygen (O2) consumption by competitively inhibiting cytochrome c
oxidase. Here, we show that endogenously released endothelial NO, either basal or stimulated, can modulate O2
consumption both throughout the thickness of conductance vessels and in the microcirculation. Furthermore, we have
shown that such modulation regulates O2 distribution to the surrounding tissues. We have demonstrated these effects by
measuring O2 consumption in blood vessels in a hypoxic chamber and O2 distribution in the microcirculation using the
fluorescent oxygen-probe Ru(phen)32. Removal of NO by physical or pharmacological means, or in eNOS/ mice,
abolishes this regulatory mechanism. Our results indicate that, in addition to its well-known effect on the regulation of
vascular tone, endothelial NO plays a major role in facilitating the distribution of O2, an action which is crucial for the
adaptation of tissues, including the vessel wall itself, to hypoxia. It is possible that changes in the distribution of O2
throughout the vessel wall may be implicated in the origin of vascular pathologies such as atherosclerosis. (Circ Res.
2009;104:1178-1183.)
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Nitric oxide (NO) synthase in the vasculature (endothelialNO synthase [eNOS]) is constantly activated by the
shear stress generated by circulating blood. The resulting NO,
which activates soluble guanylate cyclase (sGC), maintains a
vasodilator tone which is determinant in the regulation of
blood flow and pressure.1 NO also interacts with the terminal
enzyme of the electron transport chain, cytochrome c oxidase
(CcO), in a manner that is competitive with oxygen (O2),
leading to an increase in the Km of this enzyme for O2 and the
consequent inhibition of respiration.2 A number of studies in
vascular endothelial cells3 and in tissues4,5 have shown that
this results in a decrease in consumption of O2 and in its
redistribution away from mitochondria and toward other
oxygen-dependent targets.6 Thus NO plays a role in the
subcellular profile of O2 distribution. In this study, we have
investigated this phenomenon by monitoring the dynamics of
O2 consumption and its distribution both in a variety of strips
of conductance vessels from several species and in the
mesenteric circulation of rats and mice. Our results indicate
that NO plays a major role in facilitating O2 distribution in
these vascular tissues through its effect as an inhibitor of the
mitochondrial CcO. This action, which increases as the O2
concentration [O2] decreases, might be a major factor in the
adaptation of tissues to hypoxia.
Materials and Methods
Tissue Preparation
Human umbilical cords were obtained from the Department of
Gynaecology and Obstetrics of the Hospital Doctor Peset. Vascular
rings, 5 mm in length, were extracted from the middle portion of the
cords. Male Sprague–Dawley rats (200 to 250 g, Harlan Laborato-
ries, Barcelona, Spain) or wild-type (WT) and eNOS knockout
(eNOS/) mice (WT, C57BL/6Jx129, 20 to 25 g, UCL, London,
UK) were decapitated and their thoracic aortas and pulmonary and
mesenteric arteries were removed, cleaned of adhering tissues, and
cut into 5-mm (rat vessels) or 2-mm (mouse vessels) rings. When
necessary, the endothelium was disrupted by gently rubbing the
luminal surface. For the experiments with fluorescence microscopy,
a portion of the rat or mouse mesenteric arterial tree was isolated and
cleaned of surrounding fat. All experiments were performed in Krebs
solution (in 103 mol/L) (NaCl 118, KCl 4.75, CaCl2 1.9, MgSO4
1.2, KH2PO4 1.2, NaHCO3 25, and glucose 10.1). All protocols
complied with the European Community guidelines for the use of
experimental animals and were approved by the Ethics Committee of
the University of Valencia.
Contractility Studies
These experiments were performed with rat vascular rings suspended
in a 5-mL organ bath (37°C) gassed with 12% O2, 5% CO2, and 83%
N2, which produced an O2 concentration of 130106 mol/L,
similar to that present in the aortic blood,7,8 and monitored with a
dissolved O2 meter (ISO2; World Precision Instruments, Stevenage,
Herts, UK). Tension was measured isometrically with Grass FTO3
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force-displacement transducers and recorded (Power Laboratory).
An initial load of 2 g (aorta and human umbilical artery) or 1 g
(pulmonary and mesenteric arteries) was applied to each preparation
and maintained throughout the experiment. Following a 75- to
90-minute equilibration period, rings were contracted with phenyl-
ephrine (Phe) (1105 mol/L in mesenteric artery or 1106 mol/L
in pulmonary artery, aorta, and human umbilical artery), and the
presence of a functional endothelium was confirmed by eliciting a
relaxant response (95%) to acetylcholine (ACh) (1105 mol/L),
a dose that induces maximal sGC-mediated vasodilatation.7
After a further equilibration period of 30 to 45 minutes, vessels
were contracted with a depolarizing solution (60103 mol/L KCl)
to obtain the maximal level of contraction. After further washing, the
rings were allowed to equilibrate for at least 1 hour. Thereafter, they
were again stimulated with Phe and concentration–response curves
of relaxation to ACh (1109 to 1105 mol/L), bradykinin (Bk)
(1109 to 1105 mol/L), or the slow-releasing NO donor
diethylenetriamine (DETA-NO) (1108 to 1104 mol/L) were
carried out. In another set of experiments concentration-response
curves of contraction to Phe (11010 to 10106 mol/L) were
performed. The concentration (log[mol/L]) that produced 95% of
the maximal effect (pEC95) was obtained by a nonlinear regression
analysis with GraphPad software.
Electrochemical Measurement of O2 Consumption
Aortic rings from 2 rats (80 to 100 mg total wet weight) or 3 mice
(20 to 30 mg wet weight), pulmonary and mesenteric rings from 3
rats (15 to 25 mg wet weight), or human umbilical arteries (1905
mg total wet weight) were placed in gas-tight chambers containing 1
mL of Krebs solution and gently agitated at 37°C. The O2 consump-
tion by the tissue was measured with a Clark-type O2 electrode
(Rank Brothers, Bottisham, UK) calibrated with an air-saturated
Krebs solution, assuming an [O2] of 200106 mol/L. Experiments
were performed in the presence of the NO synthase inhibitor
N-nitro-L-arginine (L-NA) (1104 mol/L), the sCG inhibitor
1H-1,2,4-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), (5106 mol/
L), ACh (1105 mol/L), Bk (1105 mol/L), or Phe (1105
mol/L in mesenteric artery or 1106 mol/L in pulmonary artery,
aorta, and human umbilical artery) in intact or endothelium-denuded
vessels. Sodium cyanide (1103 mol/L) was used to confirm that
O2 consumption was mainly mitochondrial (95% to 99%). In some
experiments, the reversibility of NO-induced inhibition of respiration
was assessed by adding oxyHb (1105 mol/L) when the [O2] in the
chamber was 100106 mol/L. Measurements were obtained using
a data acquisition device, Duo18 (World Precision Instruments,
Stevenage, UK). A hyperbolic function was used to describe the
relationship between [O2] and the rate of O2 consumption (VO2).7,9,10
The apparent O2 affinity (Michaelis–Menten constant [Km])
(1106 mol/L) was calculated using the program GraphPad, and
the results are shown in the Table. VO2 was calculated at 2 specific
[O2], 130106 mol/L and 30106 mol/L, which were selected as
representing those [O2] present in arterial blood or within tissues,
respectively.7,8 VO2 was expressed as 1109 mol/L O2/min per
milligram of protein. Proteins were determined by the BCA protein
assay kit (Pierce, Rockford, Ill) using BSA as the standard.
In some cases, the viability of the rings was later assessed by
confirming that their contractile response to Phe and their relaxant
response to ACh did not differ from that of nonmanipulated vessels.
Visualization of Intracellular O2 by
Fluorescence Microscopy
Selected portions (1.51.5 cm) of the mesenteric arterial tree close
to the gut were excised and incubated in the dark (3 hours) in Krebs
solution (37°C) containing Tris(1,10-phenanthroline)ruthenium(II)
chloride hydrate [Ru(phen)32] (1104 mol/L). This fluorochrome
has recently been adapted for use as an indicator of O2 tension in
cells and tissues, where its fluorescence is inversely proportional to
the concentration of O2.11,12 Ruthenium-based oxygen-sensing
probes sense O2 in the range of 0 to 9.1 ppm at 20°C, although their
sensitivity range in tissues may differ at 37°C.13 In addition to its
strong visible absorption, efficient fluorescence, and relatively long-
lived excited state, Ru(phen)32 exhibits high O2 sensitivity, a large
Stoke shift, and high photo-/chemical stability in the cellular envi-
ronment. Because of its long emission wavelength the fluorescence
signal of the indicator is shifted away from cellular autofluorescence,
which causes serious perturbation when UV sensing indicators are
used. In our experimental conditions, ruthenium is taken up by living
cells and maintains its O2-sensing properties for at least 5 hours after
loading.
The vital cell nuclear stain Hoechst 33342 (1106 mol/L) was
added for the last 30 minutes of incubation. Samples of mesentery
between 2 vessel branches were then mounted on a purpose-built
support and transferred to a hypoxic incubator and maintained at
37°C. This system was then placed under a fluorescence microscope
(Axiovert 200M Zeiss inverted). Following equilibration for 10
minutes at atmospheric [O2] (200106 mol/L O2; the O2 concen-
tration in the tissue medium, however, was 130106 mol/L, as
monitored with a dissolved O2 meter [ISO2; World Precision
Instruments, Stevenage, Herts, UK]), samples were subjected to
hypoxia (15106 mol/L O2) for 20 minutes by the addition of
nitrogen in the presence or absence of the NO synthase inhibitor
L-NA (1104 mol/L), ACh (1105 mol/L), or DETA-NO
(1105 mol/L). Images (10 magnification) were obtained every
2 minutes throughout the entire experimental period, and changes in
Ru(phen)32 fluorescence were analyzed using a 543-nm He-Ne
laser to excite the probe. A 405-nm diode laser was used to excite
Hoechst 33342. Fluorescence was detected through 440/20 BP and
604 LP filters for Hoechst 33342 and Ru(phen)32, respectively, and
the fluorescence microscope settings were adjusted to produce the
optimum signal to noise ratio and maximum signal detection. An
analysis of the ruthenium fluorescence in individual cells was
obtained with Leica image analysis software that processed the
image stacks acquired in the region of interest. The ratio of
fluorescence intensity was calculated for each cell using imaging
software (Leica Confocal Software, version 2.61, Leica Microsys-
Table. Effect of NO on the Apparent Km for O2 in Rings From
Rat and Human Vessels
Rat Arteries
Human
Umbilical ArteryAorta Pulmonary Mesenteric
Control 23.21.3 20.73.1 29.33.1 28.61.8
L-NA 7.30.4* 10.91.0* 12.51.8* 10.10.8*
E() 8.30.6* 9.90.7* 12.91.2* 6.90.5*
ODQ 24.51.2 22.81.7 30.82.9 31.31.3
ACh 75.92.6* 42.72.3* 76.610.6* 49.42.6*
L-NA 7.60.4* 8.30.2* 11.61.3* 9.30.5*
E() 8.90.4* 7.90.1* 10.91.2* 8.40.6*
Bk 79.73.8* 46.42.8* 72.310.5* 50.66.3*
L-NA 8.30.5* 8.10.3* 12.61.3* 9.10.4*
E() 8.50.5* 9.20.2* 11.71.1* 8.70.3*
DETA 113.15.8* 78.35.2* 83.46.1* 72.54.4*
L-NA 93.82.6* 69.44.1* 78.55.1* 68.46.1*
E() 83.12.4* 66.55.3* 75.36.5* 65.68.1*
Phe 71.63.1* 38.13.6* 56.55.1* 42.25.1*
L-NA 6.60.5* 8.30.5* 9.30.4* 10.35.2*
E() 7.80.5* 7.60.6* 9.90.6* 9.60.5*
Samples were in treated with ACh (1105 mol/L), Bk (1105 mol/L),
DETA-NO (1105 mol/L), and Phe (1105 mol/L in mesenteric artery or
1106 mol/L in pulmonary artery, aorta, and human umbilical artery). In
some cases, L-NA was added or the endothelium was removed E(). Data
are meansSEM of 5–7 independent experiments. *P	0.05 vs control.
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tems GmbH, Heidelberg, Germany). At least 70 cells were analyzed
for each sample.
Further experiments were performed to exclude interference with
Ru(phen)32 fluorescence by free radicals (H2O2) and NO (DETA-
NO). Different concentrations (1109 mol/L to 1104 mol/L) of
H2O2 and DETA-NO were incubated in the presence of Ru(phen)32
(1104 mol/L) in a cell-free Krebs solution. Fluorescence was
measured with a Fluoroskan plate reader (Thermo Labsystems).
Basal fluorescence was not modified by incubation with DETA-NO
or H2O2, or either of the compounds in normoxia and hypoxia,
except at a maximal concentration of H2O2 (1104 mol/L) (n
4 to
5 experiments; results not shown).
Data Analysis
Unless otherwise stated, all results are the meansSEM of at least 5
experiments from different animals. Statistical analysis was per-
formed by 1-way ANOVA (GraphPad Software) and Student–
Newman–Keuls as a post hoc test. Significance was defined as
P	0.05.
Drugs and Solutions
Phe, ACh, Bk, L-NA, sodium cyanide, ODQ, meth(a)emoglobin,
Ru(phen)32, and Hoechst 33342 were acquired from Sigma-Aldrich
(St Louis, Mo). DETA-NO was from Alexis (Lausen, Switzerland).
OxyHb was prepared by reduction of human meth(a)emoglobin
with a 10-fold molar excess of sodium dithionite, followed by
dialysis against PBS. All drugs were dissolved in ultrapure water.
Ru(phen)32 and Hoechst 33342 were dissolved in Krebs solution
and ODQ was dissolved in DMSO (1:5000 vol:vol).
Results
Consumption of O2 by Blood Vessels
First we monitored VO2 in several isolated blood vessels
when placed in an O2-tight chamber, as previously de-
scribed.7,9,10 Figure 1A and 1B show how the rat aorta
gradually reduced its rate of O2 consumption as the [O2]
decreased. The requirement of the tissue for O2 was mainly
mitochondrial because addition of sodium cyanide resulted in
almost complete (95% to 99%) inhibition of O2 consumption
(data not shown). The reduction in the rate of consumption at
low [O2] was attenuated both by blocking NO synthesis with
L-NA and by removal of the endothelium, indicating that NO
was responsible for this effect and therefore for the observed
increase in the apparent Km for O2 (Figure 1B and the Table).
This action of NO was independent of an effect on sGC
because it was unaffected by treatment with the specific sGC
inhibitor ODQ (Table).
Figure 1C shows the consumption of O2 at 2 specific [O2]
that approximate to those of arterial blood (130106 mol/L)
and tissue (30106 mol/L), respectively.7,8 Aortas were
found to consume 50% less O2 at the lower of the 2 [O2].
This NO-dependent adaptive response was not observed only
in the aorta but in all the vessels studied, independent of
species (human, rat, mouse) or anatomic origin (placental,
systemic, or pulmonary circulation) (Table).
In aortas from eNOS knockout mice, we observed a
reduced apparent Km for O2 and similar rates of O2 consump-
tion at the high and low [O2] studied. This contrasted with the
response of tissues from WT mice, which was similar to that
of control rat aortas. The responses of tissues from the eNOS
knockout mice were similar to those exhibited by WT
controls after treatment with L-NA or endothelium denuda-
tion (Figure 1D through 1F).
Treatment of rat arteries with vasodilators such ACh
(1105 mol/L) or Bk (1105 mol/L) (EC95) (see Materi-
als and Methods) that stimulate endothelial NO generation
resulted in a greater inhibition of O2 consumption at the low
[O2] and, in addition, an inhibition of O2 consumption at the
Figure 1. Representative traces showing O2 consumption and VO2 in rings of rat (A and B) and mouse aorta from WT and eNOS KO
mice (D and E). B and E show the continuous measurement of VO2 in the absence or presence of L-NA (110
4 mol/L) in endothelium-
denuded vessels (E) and in eNOS KO mice. VO2 measured at 13010
6 mol/L and 30106 mol/L O2 are shown in C and F. Data
are meansSEM from n5 independent experiments, with *P	0.05 vs corresponding value at 130106 mol/L O2 and #P	0.05 vs
control value at 30106 mol/L O2.
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higher [O2] (Figure 2A and 2B and the Table). This did not
occur when the tissues were treated with L-NA or were
endothelium-denuded (Figure 2B). Unlike ACh or Bk, the
greater inhibition of O2 consumption and the increase in the
Km values induced by the slow-releasing NO donor
DETA-NO (1105 mol/L) were not significantly affected
either by inhibition of NO production or by removal of the
endothelium (Figure 2B). The fact that the potent vasocon-
strictor Phe (EC95) (1105 mol/L in mesenteric artery or
1106 mol/L in pulmonary artery, aorta and human umbil-
ical artery) also induced an NO-dependent decrease in the
vascular consumption of O2 (Table) ruled out the possibility
that the action of ACh, Bk, and DETA-NO was attributable to
their vasodilator properties.
Concentration of O2 in Vascular Tissue
We used the O2 probe Ru(phen)32 (1104 mol/L) to
monitor O2 concentrations under normal and hypoxic condi-
tions in ex vivo portions of rat mesenteric tissue containing at
least one blood vessel of 20 to 30 m in diameter. The
tissue was placed on a purpose-built support inside a chamber
and analyzed under a fluorescence microscope in continu-
ously regulated conditions of temperature (37°C) and gas (5%
CO2 and variable concentrations of O2), and images were
obtained every 2 minutes. Following equilibration at
200106 mol/L O2 for 10 minutes, samples were subjected
to hypoxia (15106 mol/L O2) for 20 minutes by the
addition of nitrogen. As shown in Figure 3A and 3B and the
Movies and Figure I in the online data supplement (available
at http://circres.ahajournals.org), in control experiments, this
produced a rapid build up in the concentration of O2 in the
individual cells, as shown by a decrease in red fluorescence in
their cytosol. This was not attributable to photobleaching by
the camera because there was no change in the number of
fluorescent cells if samples were maintained at 200106
mol/L O2 for 30 minutes. Furthermore, on cessation of
hypoxia, fluorescence rapidly increased toward prehypoxic
levels (data not shown). This effect of hypoxia on O2
consumption did not occur following treatment with L-NA
(Figure 3A and 3B and Online Movies), indicating that it was
NO-dependent and that an active NO synthase was generating
NO at concentrations sufficient to modulate the consumption
of O214 and divert it toward the surrounding tissues. This is
supported by the fact that sodium cyanide, which also inhibits
the CcO, produced a similar increase in the concentration of
O2 in the cells (see Online Movies).
Treatment with ACh further increased the build up of O2 in
hypoxia and the speed at which it occurred (Figure 3A and 3B
and Online Movies). Thus, on induction of hypoxia, it took
6.400.2 minutes to reduce by 50% the number of control
fluorescent cells and only 5.200.3 minutes in the presence
of ACh. Administration of the same dose of ACh at
200106 mol/L O2 also elicited a decrease in ruthenium
fluorescence that was smaller than that observed in hypoxia
but was still significant (Figure 4A and 4B and Online
Movies). This response was substantially enhanced if hypoxia
was induced subsequently. Treatment with L-NA prevented
the effects of ACh (Figure 4B) but had no effect on the
similar response induced by DETA-NO (1105 mol/L)
(data not shown). Experiments in eNOS knockout mice
further showed that, whereas mesenteric tissues from WT
mice exhibited a similar NO-dependent increase in the
concentration of tissue O2 to that obtained in rats, those from
eNOS knockout animals showed no changes in fluorescence
during hypoxia (Figure 3A and 3C and Online Movies), even
after the administration of ACh (data not shown).
Discussion
Our results indicate that both basal and stimulated release of
NO from the vascular endothelium is responsible not only for
the well-known regulation of vascular tone1 but also for the
adjustment of O2 consumption. In our experiments using
isolated blood vessels, although we studied the consumption
of O2 over a wide range of [O2], we chose to compare the
behavior of the vessels at 2 [O2], namely 130106 mol/L
and 30106 mol/L, which approximate the [O2] in arterial
blood and tissues, respectively. Our results demonstrate that
as the [O2] decreased so did the consumption of O2. In the
absence of endothelium-derived NO, following inhibition of
its synthesis with L-NA or removal of the endothelium, this
adaptive change disappeared and the vascular consumption of
O2 remained constant over a wide range of [O2]. There was
eventually a drop in consumption in the absence of NO;
however, this occurred at much lower [O2].
This modulatory effect of NO was observed in a variety of
vessels of different anatomic origin and sources, including
human, and is consistent with its known effect in reducing the
Figure 2. Effect of ACh and DETA-NO on VO2 in rat aorta. Ves-
sels were treated with ACh (1105 mol/L) or DETA-NO
(1105 mol/L) in endothelium-denuded vessels (E-) or follow-
ing incubation with L-NA (1104 mol/L). A shows the continu-
ous measurement of VO2, and B shows the VO2 measured at
130106 mol/L and 30106 mol/L O2. Data are meansSEM
from n4 independent experiments, with *P	0.05 vs control at
the corresponding O2, and #P	0.05 vs the corresponding value
at 130106 mol/L O2.
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affinity of CcO for O2 in a competitive manner, ie, increasing
its Km and adjusting mitochondrial O2 consumption.8,15 We
found that aortas from eNOS knockout mice exhibited a
reduced Km for O2 and consumed equal amounts of O2
independently of the [O2] in the medium, further indicating
that endothelium-derived NO is responsible for regulating O2
consumption.
When endothelial NO generation was increased with ACh
or Bk, at concentrations at which these agonists produced
potent sGC-mediated vasodilation,16 there was an enhanced
reduction in VO2. This occurred even at the higher [O2] and
was also prevented by treatment with L-NA or removal of the
endothelium. Administration of exogenous NO with
DETA-NO also induced a greater inhibition of O2 consump-
tion and increase in Km, which were not affected either by
inhibition of NO generation or by removal of the endotheli-
um. These results are in accordance with previous observa-
tions in cells3,9 and in tissues.4,7,17 This NO-dependent effect
on consumption of O2 was also observed in the presence of
the vasoconstrictor Phe, which is known to release NO
following activation of endothelial 1 adrenoreceptors.18
Inhibition of CcO by NO (a phenomenon that has been
called “metabolic hypoxia”8) leads to a major redistribution
of O2, which has been demonstrated in cells in culture.6,19 Our
results, obtained with fluorescence microscopy show that this
redistribution also occurs in vascular tissues in vitro. Indeed,
these experiments show that the stimulation of endothelial
NO production with ACh resulted in an increase in the
intracellular [O2] of the mesenteric cells surrounding a
microvessel, as shown by the decreased fluorescence of
Ru(phen)32. This effect could be observed even in experi-
ments carried out at 200106 mol/L O2, in which ACh was
able to generate enough NO to modulate O2 consumption.
Addition of DETA-NO and other inhibitors of mitochondrial
respiration to the vascular preparations also led to an increase
in the intracellular [O2], indicating a concentration-dependent
Figure 3. Changes in intracellular [O2] in rat and mice mesenteric cells, in close proximity to a blood vessel, when exposed to hypoxia.
The preparation was loaded with Ru(phen)3
2 (3 hours, 1104 mol/L, red fluorescence), whose fluorescence is inversely proportional
to the [O2]. Following a 10-minute equilibration period at atmospheric [O2] (20010
6 mol/L O2), samples were subjected to hypoxia
(15106 mol/L O2) for a 20-minute period by the addition of nitrogen in the presence or absence of L-NA (110
4 mol/L), ACh
(1105 mol/L), or DETA-NO (1105 mol/L). Fluorescence in individual cells was monitored at 2 minutes intervals following hypoxia,
as shown in A, where phase-contrast images of the selected area are shown (left), and the arrows show the blood vessels. B and C
show the changes in Ru(phen)3
2 fluorescence intensity expressed as a percentage of basal fluorescence. Data are meansSEM from
5 independent experiments and *P	0.05 vs value at 200106 mol/L O2 (time 0). Bar
100 m.
Figure 4. Effect of ACh on intracellular [O2] in rat mesenteric
cells, in close proximity to a blood vessel. The preparation was
loaded with Ru(phen)3
2, as described in the legend to Figure 3.
Following 10 minutes of equilibration at 200106 mol/L O2,
ACh (1105 mol/L) was added for a further 10 minutes, and
samples were then subjected to hypoxia (15106 mol/L O2) for
10 minutes in the presence or absence of L-NA (1104 mol/L).
Fluorescence in individual cells was monitored at 2-minute inter-
vals, as shown in A and B. B shows the changes in Ru(phen)3
2
fluorescence intensity expressed as a percentage of basal fluo-
rescence. Data are meansSEM from 5 independent experi-
ments and *P	0.05 vs value at 200106 mol/L O2.
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effect of NO. The reason for the paradoxical increase in
cellular [O2] when exposed to hypoxia is that in normoxia,
where O2 consumption is high, there is a steep O2 gradient
toward O2-consuming mitochondria, leaving a relatively low
level of spare O2 (hence high ruthenium fluorescence). In
hypoxia, NO-dependent inhibition of respiration leads to
decreased O2 consumption and thus a paradoxical increase in
the levels of available O2 (hence a lower number of ruthe-
nium fluorescent cells).
In conclusion, our results indicate that the basal release of
endothelial NO adjusts vascular O2 consumption. This may
occur at the level of the microcirculation to facilitate the
distribution of O2 to the tissues, especially at low [O2], as has
been indicated before.6,20,21 It may also occur in the larger
vessels, where the requirement for O2 by the vascular smooth
muscle may vary as a result of the action of hormones such as
ACh and adrenaline, as well as the activity of the different
sets of nerves that innervate the vasculature. This remains to
be studied. In addition, it is possible that changes in the
distribution of O2 throughout the vessel wall, because of a
decrease in NO production in endothelial dysfunction, may
play a role in the development of vascular disease.
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Supplement Material 
Legend for supplementary films.  
Hypoxia-induced changes in intracellular [O2] in rat and mouse mesenteric cells 
in close proximity to a blood vessel. The preparation was loaded with 
Ru(phen)3
2+ (3h, 1X10-4 mol/L µM, red fluorescence), whose fluorescence is 
inversely proportional to the [O2]. Fluorescence was filmed for a 20 min period in 
normoxia or hypoxia, recording one frame every 2 min. When tissues were 
subjected to hypoxia following normoxia, the first frame was taken in normoxia 
and the subsequent frames in hypoxia. (A) Control normoxia, (B) control 
hypoxia, (C) hypoxia in the presence of L-NA, (D) hypoxia in the presence of 
ACh, (E) hypoxia in the presence of DETA-NO, (F) normoxia in the presence of 
cyanide, (G) hypoxia in cells from eNOS -/- mice, (H) addition of ACh in the 
presence of normoxia, and (I) hypoxia in the presence of ACh. 
 
Online Figure I. 
Representative images of cells from the mesenterium showing the changes that 
took place in intracellular [O2] when exposed to hypoxia (nucleus stained with 
Hoescht (blue), O2 stained with Ru(phen)3
2+ (red) in the cytosol of the cells). The 
preparation was loaded with Ru(phen)3
2+ (3h, 1X10-4 mol/L, red fluorescence), 
whose fluorescence is inversely proportional to the [O2]. The vital cell nuclear 
stain Hoechst 33342 (1X10-6 mol/L) was added for the last 30 min of incubation. 
Following a 10 min equilibration period at atmospheric [O2] (200X10
-6 mol/L O2), 
samples were subjected to hypoxia (15X10-6 mol/L O2) for a 20 min period by the 
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addition of nitrogen.  The panels on the left show the merged fluorescence of 
Hoescht (blue) and Ru(phen) 3
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